Skip to main content

Animations

MJFF Publications

4931 - 4940 of 6564 Results
Title
Year
  • Year
  • 2025
  • 2020
  • 2017
  • 2020
  • 2023
  • 2023
  • 2019
  • 2018
  • 2021
  • 2023
  • Summary Details
    OPEN
    Title: Progressive supranuclear palsy against everyone else: a look into the specificity of MRI markers
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.jns.2025.123731
    Citation Count: 1
  • Summary Details
    OPEN
    Title: White Matter Hyperintensities Related to Parkinson's Disease Executive Function
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mdc3.12956
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Ubiquitin Linkage-Specific Affimers Reveal Insights into K6-Linked Ubiquitin Signaling
    Journal Name: Molecular Cell
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.molcel.2017.08.020
    Citation Count: 194
  • Summary Details
    OPEN
    Title: The cerebral tremor circuit in a patient with Holmes tremor
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51143
    Citation Count: 15
  • Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy
    2023
    Summary Details
    OPEN
    Title: Wearable sensors for assessing disease severity and progression in Progressive Supranuclear Palsy
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2023.105345
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2023.114370
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Identification of β-synuclein on secretory granules in chromaffin cells and the effects of α- and β-synuclein on post-fusion BDNF discharge and fusion pore expansion
    Journal Name: Neuroscience Letters
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neulet.2019.01.056
    Citation Count: 10
  • Summary Details
    OPEN
    Title: The GBA p.Trp378Gly mutation is a probable French‐Canadian founder mutation causing Gaucher disease and synucleinopathies
    Journal Name: Clinical Genetics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/cge.13405
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105409
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Identification of a Putative α-synuclein Radioligand Using an in silico Similarity Search
    Journal Name: Molecular Imaging and Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11307-023-01814-9
    Citation Count: 17
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.